Actively Recruiting
Effects of LP28 on Immunity Enhancement in the Elderly
Led by Synbio Tech Inc. · Updated on 2024-12-09
100
Participants Needed
2
Research Sites
50 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Due to the increasing attention on aging-related health issues, this study focuses on the elderly population as participants. The aim is to investigate whether supplementation with Lactobacillus plantarum LP28 can effectively enhance immunity, reduce the frequency and severity of common cold infections, and ultimately promote overall health in the elderly.
CONDITIONS
Official Title
Effects of LP28 on Immunity Enhancement in the Elderly
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 50 and 75 years
- Experienced symptoms of common cold or tonsillitis at least twice in the past year
You will not qualify if you...
- Diagnosed liver, kidney, immune, or neoplastic diseases
- History of mental illnesses such as schizophrenia or depression
- Current allergic rhinitis
- Current drug or alcohol dependence
- Any condition deemed inappropriate by the researcher for participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
National Chung Hsing University
Taichung, Taiwan, 402202
Actively Recruiting
2
Taichung Veterans General Hospital
Taichung, Taiwan, 407219
Actively Recruiting
Research Team
H
Han-Yin Hsu
CONTACT
C
Chia-Chia Lee, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here